Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines - Scientific guideline

HumanScientific guidelines

On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.

Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines.

Keywords: /

Current effective version

Public statement on the evaluation of bovine spongiform encephalopathies (BSE) - risk via the use of materials of bovine origin in or during the manufacture of vaccines

Adopted Reference Number: EMEA/CPMP/BWP/476/01 Legal effective date: 28/02/2001

English (EN) (21.44 KB - PDF)

First published: 28/02/2001 Last updated: 28/02/2001

View

Topics

Scientific guidelines

Evaluation of bovine spongiform encephalopathies (BSE)-risk via the use of materials of bovine origin in or during the manufacture of vaccines - Scientific guideline

Current effective version

Related content

Topics

Share this page